6,486 Studies Reviewed. 85.2% of Original Studies Found Biological Effects. The Evidence is Clear.

Radiofrequency fields, transthyretin, and Alzheimer's disease

Bioeffects Seen

Söderqvist F, Hardell L, Carlberg M, Mild KH · 2010

View Original Abstract
Share:

A study of 313 subjects found a statistically significant association between longer time since first use of mobile and cordless phones and higher serum transthyretin levels.

Plain English Summary

Summary written for general audiences

Researchers proposed that transthyretin (TTR), a protein that sequesters amyloid-beta, might help explain findings related to radiofrequency exposure and Alzheimer's disease. In a provocation study on 41 persons exposed for 30 minutes to an 890-MHz GSM signal at 1.0 Watt/kg to the temporal area of the brain, serum TTR was found to be statistically significantly increased 60 minutes after exposure. In a cross-sectional study on 313 subjects, a statistically significantly positive association was found between serum TTR and time since first use of mobile phones and desktop cordless phones combined (P=0.03).

Why This Matters

Studies have shown that patients with Alzheimer's disease have lowered TTR concentrations in the cerebrospinal fluid, and researchers have attributed the onset of Alzheimer's disease to insufficient sequestering of amyloid-beta by TTR. The researchers used serum TTR as a marker of cerebrospinal fluid TTR in their cross-sectional study. In the cross-sectional study, use of oral snuff also yielded statistically significantly increased serum TTR concentrations. Nicotine has been associated with decreased risk for Alzheimer's disease and with upregulation of the TTR gene in choroid plexus but not in the liver, another source of serum TTR. The researchers proposed that TTR might be involved in the findings of radiofrequency exposure benefit in Alzheimer's disease mice.

Exposure Details

SAR
1 W/kg
Source/Device
890-MHz GSM
Exposure Duration
30 min

Exposure Context

This study used 1 W/kg for SAR (device absorption):

Building Biology guidelines are practitioner-based limits from real-world assessments. BioInitiative Report recommendations are based on peer-reviewed science. Check Your Exposure to compare your own measurements.

Where This Falls on the Concern Scale

Study Exposure Level in ContextStudy Exposure Level in ContextThis study: 1 W/kgExtreme Concern - 0.1 W/kgFCC Limit - 1.6 W/kgEffects observed in the Extreme Concern range (Building Biology)FCC limit is 2 times higher than this level
A logarithmic frequency spectrum from 10 Hz to 100 GHz showing where this study's 890 MHz exposure sits relative to common EMF sources.Where This Frequency Sits on the EMF SpectrumELFVLFLF / MFHF / VHFUHFSHFmm10 Hz100 GHzThis study: 890 MHzPower lines50/60 Hz5G mm28 GHzLogarithmic scale

Study Details

Based on our studies on humans on RF from wireless phones, we propose that transthyretin (TTR) might explain the findings.

In a cross-sectional study on 313 subjects, we used serum TTR as a marker of cerebrospinal fluid TT...

In a provocation study on 41 persons exposed for 30 min to an 890-MHz GSM signal with specific absor...

We propose that TTR might be involved in the findings of RF exposure benefit in AD mice.

Cite This Study
Söderqvist F, Hardell L, Carlberg M, Mild KH (2010). Radiofrequency fields, transthyretin, and Alzheimer's disease J Alzheimers Dis. 20(2):599-606, 2010.
Show BibTeX
@article{f_2010_radiofrequency_fields_transthyretin_and_122,
  author = {Söderqvist F and Hardell L and Carlberg M and Mild KH},
  title = {Radiofrequency fields, transthyretin, and Alzheimer's disease},
  year = {2010},
  
  url = {https://content.iospress.com/articles/journal-of-alzheimers-disease/jad01395},
}

Quick Questions About This Study

Transthyretin (TTR) sequesters amyloid-beta, thereby preventing the formation of amyloid-beta plaques in the brain, and researchers proposed it might explain findings related to radiofrequency exposure.
Serum TTR was statistically significantly increased 60 minutes after 30 minutes of exposure to an 890-MHz GSM signal at 1.0 Watt/kg to the temporal area of the brain.
The study found a statistically significantly positive association between serum TTR and time since first use of mobile phones and desktop cordless phones combined (P=0.03).
Patients with Alzheimer's disease have been shown to have lowered TTR concentrations in the cerebrospinal fluid, and researchers have attributed the onset of the disease to insufficient sequestering of amyloid-beta by TTR.
The researchers reported that the electromagnetic field parameters were similar for mobile phones and desktop cordless phones.